Orthopedic Disorders, Pain, Postoperative Pain, Total Knee Arthroplasty, Total Knee Replacement
Conditions
Keywords
electrical stimulation, neurostimulation, neuromodulation, TKA pain, pain following total knee replacement, total knee arthroplasty
Brief summary
The purpose of this study is to determine if electrical stimulation (small levels of electricity) can safely and effectively reduce pain following total knee replacement (or total knee arthroplasty (TKA)). This study involves a device called the SPRINT System. The SPRINT System delivers mild electrical stimulation to nerves in the leg that received the knee replacement. The SPRINT System includes a small wire (called a lead) that is placed through the skin in the upper leg. It also includes a device worn on the body that delivers stimulation (called the SPRINT Stimulator).
Interventions
The SPRINT System is an Investigational Device which delivers mild electrical stimulation to nerves in the leg that underwent lead placement. The SPRINT System includes a small wire (called a Lead) that is placed through the skin in the upper leg. It also includes a device worn on the body that delivers stimulation (called the SPRINT Stimulator).
Sponsors
Study design
Eligibility
Inclusion criteria
Key Inclusion Criteria: * At least 21 years old * Scheduled to undergo a primary unilateral total knee replacement procedure Key
Exclusion criteria
* Body Mass Index (BMI) \> 40 kg/m2 * Compromised immune system based on medical history * History of valvular heart disease * Implanted electronic device * Joint or overlying skin infection of the affected limb * History of recurrent skin infections * Bleeding disorder * Allergy to skin surface electrodes and/or medical-grade adhesive tapes * Pregnant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average Knee Pain While Walking | Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA)) | Subjects were asked to complete daily diaries to track their average pain intensity while walking during the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean scores for weeks 1-4 is reported. |
| Number of Participants That Experienced at Least One Study-Related Adverse Event | Total of 21 months (from when the first subjects enrolled to when the last subject completed the study) | At each study visit following the baseline assessment at Visit 1, subjects were questioned if any changes in their medical status or condition has occurred since their previous visit. If the subject experienced a change that was an adverse event, an Adverse Event Form was completed by the site. The number of subjects that experienced at least one study-related adverse event is reported here. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Amount of Analgesic Usage | Visit 4 (Day of Surgery) and Visits 6-11 (weeks 1-6 post-Total Knee Arthroplasty (TKA)) | The amount and type of analgesics used by subjects was recorded in daily diaries. Narcotic usage was converted into a morphine equivalent dosage (MED), which is measured in units of morphine milligram equivalents (MME). Diaries were collected at various visits throughout the study, and for consistency, these data were translated into post-operative days. The average MED was calculated for each subject for the first 42 days (6 weeks) following surgery, and the median of these averages was determined across subjects. |
| Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 1 (Baseline), Visit 2 (Lead Placement), Visits 5-13 (in-hospital days through 3-months post-Total Knee Arthroplasty (TKA)) | Throughout the study, subjects were asked if they experienced any side effects related to opioid pain medications. The occurrences of these side effects were recorded and were not reported as Adverse Events. The number of subjects that experienced at least one opioid-related side effect at each visit is reported. |
| Time to Achieve 90 Degrees Flexion in Affected Knee | Visit 2 (Lead Placement), Visit 7 (3-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA) | Active range of motion (AROM; no assistance from clinical staff) and passive range of motion (PROM; assisted by clinical staff) was assessed with both stimulation on and off. The time that it took subjects to achieve the milestone of 90 degrees of knee flexion in their affected leg is reported. |
| Timed Up and Go (TUG) Test | Visit 1 (Baseline), Visit 5 (In-Hospital), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA) | Subjects began this test from a seated position in a standard chair and were timed while they stood up, walked to a marked point 10 feet away (at a normal, safe pace), returned to the chair, and sat down. Timed Up and Go (TUG) test times are expected to be greater immediately after surgery as compared to baseline. |
| 6 Minute Walk Test (6MWT) | Visit 1 (Baseline), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA) | The total distance that a subject could walk in 6 minutes was recorded, and the mean distance was determined across subjects. 6 Minute Walk Test distances are expected to be reduced immediately after surgery as compared to baseline. |
| Fixed Distance Walk Test | Visit 1 (Baseline) and Visit 5 (In-Hospital) | The amount of time it took subjects to walk a fixed distance of 20 meters was recorded. |
| Average Knee Pain Over the Last 24 Hours | Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA)) | Subjects were asked to complete daily diaries to track their average pain intensity in the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean score for weeks 1-4 is reported. |
| Knee Pain Interference With Daily Activities | Visit 1 (Baseline), Visit 2 (Lead Placement), Visits 5-13 (in-hospital days through 3-months post-Total Knee Arthroplasty (TKA)) | Subjects were asked to rate the degree to which their knee pain has interfered with 7 different aspects of their daily life on a scale from 0 to 10, with higher scores indicating greater interference. Those 7 scores were averaged for each subject to provide an overall pain interference score, with a possible range of 0 to 10 with higher scores indicating greater interference. The median score was then calculated across subjects. |
| Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visits 5-13 (in-hospital through 3-months post-Total Knee Arthroplasty (TKA)) | The Patient Global Impression of Change (PGIC) asks subjects to rate their improvement with treatment on a 7-point scale ranging from very much worse to very much improved as compared to before their knee replacement surgery. The subjects combine all the components of their experience into one overall score. Ratings of Much- or Very Much Improved are considered Meaningful Improvements; similarly, ratings of Much- or Very Much Worse are categorized as Meaningfully Worse. |
| Pain Catastrophizing Scale (PCS) | Visit 1 (Baseline), Visit 11 (6-weeks post-Total Knee Arthroplasty (TKA)), Visit 13 (3-months post-TKA) | The Pain Catastrophizing Scale (PCS) questionnaire has 13 questions that assess rumination, magnification, and helplessness. Subjects are asked to think back on painful experiences in the past and reflect on how often they had specific thoughts or feelings. Each of the 13 questions is scored on a 5-point scale where 0 represents not at all, and 4 represents all the time. The scores from each question were summed for each subject to provide a total PCS score, with a possible range from 0 to 52 with higher scores indicating a greater tendency to catastrophize pain (i.e. a higher score indicates a worse outcome). The median scores were then calculated across all subjects. |
| Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | From Day of Surgery through completion of milestone or 3-months from Day of Surgery, whichever came first | Participants were queried weekly from the date of their Total Knee Arthroplasty (TKA) until they met specific, post-surgical recovery milestones. Participants were queried up through the time at which they meet each milestone or through their completion of the study, whichever came first (up to three months post-surgery). |
| Subject Satisfaction Survey | Visit 11 (6-weeks post-Total Knee Arthroplasty (TKA)) | Subjects completed a sponsor-developed survey with questions pertaining to their feelings about the SPRINT Stimulation System as a method for managing post-surgical pain. |
| Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC) | Visit 1 (Baseline), Visit 5 (In-Hospital), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA) | The Western Ontario McMaster University Osteoarthritis Index (WOMAC) questionnaire consists of 24 items that evaluate pain, stiffness, and physical functional disability. Each item is scored on an 11-point numerical rating scale from 0 to 10, where higher scores indicate greater pain, stiffness, and disability. For each subject, the scores from each of the 24 items were summed to calculate the subject's total score, with a minimum score of 0 and a maximum score of 240. Percent change from baseline was calculated for each subject at each time point (i.e., value at Visit 5 vs. Baseline rating, value at Visit 7 vs. Baseline rating, value at Visit 11 vs. Baseline rating, and value at Visit 13 vs. Baseline rating). The median percent change across subjects was determined. Negative values indicate worsening since Baseline, while positive values indicate improvement from Baseline. Percent improvement = 100 x (\[rating at each study visit\]-\[rating at baseline\]) / \[rating at baseline\]. |
| Average Knee Pain at Rest | Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA)) | Subjects were asked to complete daily diaries to track their average pain intensity at rest in the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean score for weeks 1-4 is reported. |
Countries
United States
Participant flow
Recruitment details
Recruitment began September 2015 (with first subject enrollment in October 2015) and was concluded in February 2017. Subjects were screened for the study from a pool of candidates scheduled to undergo a primary unilateral total knee replacement procedure.
Pre-assignment details
After obtaining informed consent, subjects were evaluated for eligibility.
Participants by arm
| Arm | Count |
|---|---|
| Enrolled/Received Leads This group includes subjects that were consented, met eligibility criteria, and received Leads. | 24 |
| Total | 24 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Screen Failure | 3 |
| Overall Study | Withdrawal by Subject | 4 |
Baseline characteristics
| Characteristic | Enrolled/Received Leads |
|---|---|
| Affected Leg Left Leg | 10 Participants |
| Affected Leg Right Leg | 14 Participants |
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 9 Participants |
| Age, Categorical Between 18 and 65 years | 15 Participants |
| Age, Continuous | 67.9 years STANDARD_DEVIATION 8.7 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 1 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 23 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 1 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 22 Participants |
| Reason for Total Knee Arthroplasty (TKA) Osteoarthritis | 24 Participants |
| Reason for Total Knee Arthroplasty (TKA) Other | 0 Participants |
| Reason for Total Knee Arthroplasty (TKA) Post-Traumatic Arthritis | 0 Participants |
| Reason for Total Knee Arthroplasty (TKA) Rheumatoid Arthritis | 0 Participants |
| Reason for Total Knee Arthroplasty (TKA) Trauma | 0 Participants |
| Region of Enrollment United States | 24 participants |
| Sex: Female, Male Female | 15 Participants |
| Sex: Female, Male Male | 9 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 24 |
| other Total, other adverse events | 18 / 24 |
| serious Total, serious adverse events | 1 / 24 |
Outcome results
Average Knee Pain While Walking
Subjects were asked to complete daily diaries to track their average pain intensity while walking during the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean scores for weeks 1-4 is reported.
Time frame: Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA))
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Average Knee Pain While Walking | 3.8 Scores on a scale | Standard Error 0.34 |
Number of Participants That Experienced at Least One Study-Related Adverse Event
At each study visit following the baseline assessment at Visit 1, subjects were questioned if any changes in their medical status or condition has occurred since their previous visit. If the subject experienced a change that was an adverse event, an Adverse Event Form was completed by the site. The number of subjects that experienced at least one study-related adverse event is reported here.
Time frame: Total of 21 months (from when the first subjects enrolled to when the last subject completed the study)
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Study-Related Adverse Event | 15 Participants |
6 Minute Walk Test (6MWT)
The total distance that a subject could walk in 6 minutes was recorded, and the mean distance was determined across subjects. 6 Minute Walk Test distances are expected to be reduced immediately after surgery as compared to baseline.
Time frame: Visit 1 (Baseline), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA)
Population: One subject at Visit 1 and two subjects at Visit 7 were physically unable to complete the test. Data was not collected for an additional subject at Visit 7.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | 6 Minute Walk Test (6MWT) | Visit 1 (Baseline) | 363.0 meters | Standard Error 15.14 |
| Underwent Total Knee Arthroplasty (TKA) | 6 Minute Walk Test (6MWT) | Visit 7 (2-weeks Post-TKA) | 289.0 meters | Standard Error 21.55 |
| Underwent Total Knee Arthroplasty (TKA) | 6 Minute Walk Test (6MWT) | Visit 11 (6-weeks Post-TKA) | 365.8 meters | Standard Error 17.87 |
| Underwent Total Knee Arthroplasty (TKA) | 6 Minute Walk Test (6MWT) | Visit 13 (3-months Post-TKA) | 410.3 meters | Standard Error 16.78 |
Amount of Analgesic Usage
The amount and type of analgesics used by subjects was recorded in daily diaries. Narcotic usage was converted into a morphine equivalent dosage (MED), which is measured in units of morphine milligram equivalents (MME). Diaries were collected at various visits throughout the study, and for consistency, these data were translated into post-operative days. The average MED was calculated for each subject for the first 42 days (6 weeks) following surgery, and the median of these averages was determined across subjects.
Time frame: Visit 4 (Day of Surgery) and Visits 6-11 (weeks 1-6 post-Total Knee Arthroplasty (TKA))
Population: Data was not available for: one subject during Post-op Week 1, three subjects for Weeks 2 and 4, four subjects during Weeks 3 and 5, and for seven subjects during Post-op Week 6.
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Amount of Analgesic Usage | 15.9 MME (Morphine Milligram Equivalents) |
Average Knee Pain at Rest
Subjects were asked to complete daily diaries to track their average pain intensity at rest in the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean score for weeks 1-4 is reported.
Time frame: Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA))
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Average Knee Pain at Rest | 2.9 Scores on a scale | Standard Error 0.29 |
Average Knee Pain Over the Last 24 Hours
Subjects were asked to complete daily diaries to track their average pain intensity in the past 24 hours over a 7-day period on an 11-point numerical rating scale where 0 represents No Pain and 10 represents Pain as bad as you can imagine. The average score for each diary period was calculated across subjects, and the mean score for weeks 1-4 is reported.
Time frame: Postoperative Day 0 to 28 (first 4 weeks following Total Knee Arthroplasty (TKA))
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Average Knee Pain Over the Last 24 Hours | 3.5 Scores on a scale | Standard Error 0.3 |
Fixed Distance Walk Test
The amount of time it took subjects to walk a fixed distance of 20 meters was recorded.
Time frame: Visit 1 (Baseline) and Visit 5 (In-Hospital)
Population: One subject at Visits 1 and 5 was physically unable to complete the test. Data was not collected for two additional subjects at Visit 5, and another subject walked a fixed distance greater than 20 meters during the test so their results are not comparable.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Fixed Distance Walk Test | Visit 1 (Baseline) | 18.1 seconds |
| Underwent Total Knee Arthroplasty (TKA) | Fixed Distance Walk Test | Visit 5 (In-Hospital) | 48.5 seconds |
Knee Pain Interference With Daily Activities
Subjects were asked to rate the degree to which their knee pain has interfered with 7 different aspects of their daily life on a scale from 0 to 10, with higher scores indicating greater interference. Those 7 scores were averaged for each subject to provide an overall pain interference score, with a possible range of 0 to 10 with higher scores indicating greater interference. The median score was then calculated across subjects.
Time frame: Visit 1 (Baseline), Visit 2 (Lead Placement), Visits 5-13 (in-hospital days through 3-months post-Total Knee Arthroplasty (TKA))
Population: Data was not collected for: 10 subjects at Visit 2, two subjects at Visit 10, and one subject at Visit 12.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 10 (5-weeks Post-TKA) | 1.8 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 1 (Baseline) | 4.2 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 2 (Lead Placement) | 4.4 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 5 (In-Hospital) | 3.6 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 6 (1-week Post-TKA) | 3.1 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 7 (2-weeks Post-TKA) | 3.1 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 8 (3-weeks Post-TKA) | 2.4 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 9 (4-weeks Post-TKA) | 3.6 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 11 (6-weeks Post-TKA) | 1.5 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 12 (2-months Post-TKA) | 0.3 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Knee Pain Interference With Daily Activities | Visit 13 (3-months Post-TKA) | 0.1 Scores on a scale |
Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey
The Patient Global Impression of Change (PGIC) asks subjects to rate their improvement with treatment on a 7-point scale ranging from very much worse to very much improved as compared to before their knee replacement surgery. The subjects combine all the components of their experience into one overall score. Ratings of Much- or Very Much Improved are considered Meaningful Improvements; similarly, ratings of Much- or Very Much Worse are categorized as Meaningfully Worse.
Time frame: Visits 5-13 (in-hospital through 3-months post-Total Knee Arthroplasty (TKA))
Population: Data was not collected for two subjects at Visit 5, for three subjects at Visit 10, and for one subject at Visit 12.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 5 (In-Hospital) | Minimal or No Change | 8 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 6 (1-week Post-TKA) | Meaningful Improvement | 6 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 13 (3-months Post-TKA) | Meaningful Improvement | 19 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 13 (3-months Post-TKA) | Minimal or No Change | 1 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 5 (In-Hospital) | Meaningful Improvement | 3 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 5 (In-Hospital) | Meaningfully Worse | 7 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 6 (1-week Post-TKA) | Minimal or No Change | 11 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 6 (1-week Post-TKA) | Meaningfully Worse | 3 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 7 (2-weeks Post-TKA) | Meaningful Improvement | 6 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 7 (2-weeks Post-TKA) | Minimal or No Change | 11 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 7 (2-weeks Post-TKA) | Meaningfully Worse | 3 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 8 (3-weeks Post-TKA) | Meaningful Improvement | 9 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 8 (3-weeks Post-TKA) | Minimal or No Change | 9 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 8 (3-weeks Post-TKA) | Meaningfully Worse | 2 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 9 (4-weeks Post-TKA) | Meaningful Improvement | 5 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 9 (4-weeks Post-TKA) | Minimal or No Change | 13 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 9 (4-weeks Post-TKA) | Meaningfully Worse | 2 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 10 (5-weeks Post-TKA) | Meaningful Improvement | 8 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 10 (5-weeks Post-TKA) | Minimal or No Change | 9 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 10 (5-weeks Post-TKA) | Meaningfully Worse | 0 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 11 (6-weeks Post-TKA) | Meaningful Improvement | 11 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 11 (6-weeks Post-TKA) | Minimal or No Change | 7 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 11 (6-weeks Post-TKA) | Meaningfully Worse | 2 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 12 (2-months Post-TKA) | Meaningful Improvement | 15 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 12 (2-months Post-TKA) | Minimal or No Change | 3 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 12 (2-months Post-TKA) | Meaningfully Worse | 1 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants Reporting Meaningful Improvement, Minimal or No Change, or Meaningful Worsening on the Patient Global Impression of Change (PGIC) Survey | Visit 13 (3-months Post-TKA) | Meaningfully Worse | 0 Participants |
Number of Participants That Experienced at Least One Opioid-Related Side Effect
Throughout the study, subjects were asked if they experienced any side effects related to opioid pain medications. The occurrences of these side effects were recorded and were not reported as Adverse Events. The number of subjects that experienced at least one opioid-related side effect at each visit is reported.
Time frame: Visit 1 (Baseline), Visit 2 (Lead Placement), Visits 5-13 (in-hospital days through 3-months post-Total Knee Arthroplasty (TKA))
Population: Data was not collected for: eight subjects at Visit 2, two subjects at Visit 10, and one subject at Visit 12.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 1 (Baseline) | 7 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 2 (Lead Placement) | 1 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 5 (In-Hospital) | 13 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 6 (1-week Post-TKA) | 17 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 7 (2-weeks Post-TKA) | 11 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 8 (3-weeks Post-TKA) | 11 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 9 (4-weeks Post-TKA) | 9 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 10 (5-weeks Post-TKA) | 7 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 11 (6-weeks Post-TKA) | 4 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 12 (2-months Post-TKA) | 2 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Number of Participants That Experienced at Least One Opioid-Related Side Effect | Visit 13 (3-months Post-TKA) | 1 Participants |
Pain Catastrophizing Scale (PCS)
The Pain Catastrophizing Scale (PCS) questionnaire has 13 questions that assess rumination, magnification, and helplessness. Subjects are asked to think back on painful experiences in the past and reflect on how often they had specific thoughts or feelings. Each of the 13 questions is scored on a 5-point scale where 0 represents not at all, and 4 represents all the time. The scores from each question were summed for each subject to provide a total PCS score, with a possible range from 0 to 52 with higher scores indicating a greater tendency to catastrophize pain (i.e. a higher score indicates a worse outcome). The median scores were then calculated across all subjects.
Time frame: Visit 1 (Baseline), Visit 11 (6-weeks post-Total Knee Arthroplasty (TKA)), Visit 13 (3-months post-TKA)
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Pain Catastrophizing Scale (PCS) | Visit 11 (6-weeks Post-TKA) | 2.0 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Pain Catastrophizing Scale (PCS) | Visit 1 (Baseline) | 5.5 Scores on a scale |
| Underwent Total Knee Arthroplasty (TKA) | Pain Catastrophizing Scale (PCS) | Visit 13 (3-months Post-TKA) | 0.0 Scores on a scale |
Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC)
The Western Ontario McMaster University Osteoarthritis Index (WOMAC) questionnaire consists of 24 items that evaluate pain, stiffness, and physical functional disability. Each item is scored on an 11-point numerical rating scale from 0 to 10, where higher scores indicate greater pain, stiffness, and disability. For each subject, the scores from each of the 24 items were summed to calculate the subject's total score, with a minimum score of 0 and a maximum score of 240. Percent change from baseline was calculated for each subject at each time point (i.e., value at Visit 5 vs. Baseline rating, value at Visit 7 vs. Baseline rating, value at Visit 11 vs. Baseline rating, and value at Visit 13 vs. Baseline rating). The median percent change across subjects was determined. Negative values indicate worsening since Baseline, while positive values indicate improvement from Baseline. Percent improvement = 100 x (\[rating at each study visit\]-\[rating at baseline\]) / \[rating at baseline\].
Time frame: Visit 1 (Baseline), Visit 5 (In-Hospital), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA)
Population: Data was not collected for two subjects at Visit 5.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC) | Visit 5 (In-Hospital) | -2.3 percent change |
| Underwent Total Knee Arthroplasty (TKA) | Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC) | Visit 7 (2-weeks Post-TKA) | 39.0 percent change |
| Underwent Total Knee Arthroplasty (TKA) | Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC) | Visit 11 (6-weeks Post-TKA) | 64.5 percent change |
| Underwent Total Knee Arthroplasty (TKA) | Percent Change From Baseline on the Western Ontario McMaster University Osteoarthritis Index (WOMAC) | Visit 13 (3-months Post-TKA) | 88.5 percent change |
Subject Satisfaction Survey
Subjects completed a sponsor-developed survey with questions pertaining to their feelings about the SPRINT Stimulation System as a method for managing post-surgical pain.
Time frame: Visit 11 (6-weeks post-Total Knee Arthroplasty (TKA))
Population: Two subjects did not answer the question regarding the amount of time it took to feel pain relief from stimulation.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Tolerated Lead placement with some/no discomfort | 17 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Reported stimulation felt comfortable/soothing | 10 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Reported immediate pain relief (0-5 minutes) | 8 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Would recommend stimulation therapy to a friend | 12 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Prefer stimulation therapy to pain medication use | 14 Participants |
| Underwent Total Knee Arthroplasty (TKA) | Subject Satisfaction Survey | Wanted stimulation for longer time period | 1 Participants |
Timed Up and Go (TUG) Test
Subjects began this test from a seated position in a standard chair and were timed while they stood up, walked to a marked point 10 feet away (at a normal, safe pace), returned to the chair, and sat down. Timed Up and Go (TUG) test times are expected to be greater immediately after surgery as compared to baseline.
Time frame: Visit 1 (Baseline), Visit 5 (In-Hospital), Visit 7 (2-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA)
Population: Data was not collected for two subjects at Visit 5 and another subject was physically unable to complete the test. Data was not collected for one subject at Visit 7.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Timed Up and Go (TUG) Test | Time at Visit 1 (Baseline) | 12.3 Seconds |
| Underwent Total Knee Arthroplasty (TKA) | Timed Up and Go (TUG) Test | Time at Visit 5 (In-Hospital) | 39.0 Seconds |
| Underwent Total Knee Arthroplasty (TKA) | Timed Up and Go (TUG) Test | Time at Visit 7 (2-weeks Post-TKA) | 13.9 Seconds |
| Underwent Total Knee Arthroplasty (TKA) | Timed Up and Go (TUG) Test | Time at Visit 11 (6-weeks Post-TKA) | 10.5 Seconds |
| Underwent Total Knee Arthroplasty (TKA) | Timed Up and Go (TUG) Test | Time at Visit 13 (3-months Post-TKA) | 8.7 Seconds |
Time to Achieve 90 Degrees Flexion in Affected Knee
Active range of motion (AROM; no assistance from clinical staff) and passive range of motion (PROM; assisted by clinical staff) was assessed with both stimulation on and off. The time that it took subjects to achieve the milestone of 90 degrees of knee flexion in their affected leg is reported.
Time frame: Visit 2 (Lead Placement), Visit 7 (3-weeks Post-Total Knee Arthroplasty (TKA)), Visit 11 (6-weeks Post-TKA), Visit 13 (3-months Post-TKA)
Population: Three subjects did not meet 90 degrees of flexion with stimulation on by Visit 11 (End of Treatment) for both active range of motion (AROM) and passive range of motion (PROM). Data was not collected for four subjects for PROM with stimulation on and for three subjects for AROM with stimulation on.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Time to Achieve 90 Degrees Flexion in Affected Knee | AROM - Stimulation On | 16.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Achieve 90 Degrees Flexion in Affected Knee | PROM - Stimulation Off | 40.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Achieve 90 Degrees Flexion in Affected Knee | PROM - Stimulation On | 16.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Achieve 90 Degrees Flexion in Affected Knee | AROM - Stimulation Off | 36.5 days |
Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA)
Participants were queried weekly from the date of their Total Knee Arthroplasty (TKA) until they met specific, post-surgical recovery milestones. Participants were queried up through the time at which they meet each milestone or through their completion of the study, whichever came first (up to three months post-surgery).
Time frame: From Day of Surgery through completion of milestone or 3-months from Day of Surgery, whichever came first
Population: Data were not available for climbing stairs and discharge destination for 3 subjects and for discharge criteria and clearance to drive for one. Data were not collected for clearance to work in 2 subjects, and 10 subjects were retired. Opioid cessation data were not collected for 1 subject, and 2 subjects did not cease opioids during the study.
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Pain controlled without nerve block | 1.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Walked with assistive device | 1.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Walked without assistive device | 19.5 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Walked 30 meters | 1.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Able to climb half flight of stairs | 7.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Met hospital discharge criteria | 1.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Discharged from hospital | 1.5 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Cleared to drive | 28.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Returned to work | 24.0 days |
| Underwent Total Knee Arthroplasty (TKA) | Time to Meet Recovery Milestones up to Three Months Post-Total Knee Arthroplasty (TKA) | Cessation of all opioid medications | 34.0 days |